Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Isarna Therapeutics GmbH

www.isarna-therapeutics.com

Latest From Isarna Therapeutics GmbH

Deals Shaping The Medical Industry, November 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October 2015.

BioPharmaceutical Medical Device

Life Science Start-Ups: Venture Funding, June 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2014.

BioPharmaceutical Medical Device

Isarna Therapeutics Attracts New Investment For Next-Generation Antisense Drugs

Following a Phase III disappointment with its lead anticancer candidate, Germany’s Isarna Therapeutics has garnered new funding to advance its preclinical pipeline of oligonucleotides targeting TGF-beta.

BioPharmaceutical Germany

Apceth names chief business officer

Cell therapy firm Apceth has appointed Dr Stefanos Theoharis to the newly created position of chief business officer. Prior to joining Munich, Germany-based Apceth – a developer of stem cell-based therapies for the treatment of malignant and non-malignant diseases – Dr Theoharis was head of business development at Antisense Pharma.

Germany
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Antisense Pharma GMBH
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Isarna Therapeutics GmbH
  • Senior Management
  • Philippe Calais, CEO
  • Contact Info
  • Isarna Therapeutics GmbH
    Phone: (49) 89 890831 0
    Leopoldstrasse 254-256
    Munich, 80807
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register